Zobrazeno 1 - 10
of 66
pro vyhledávání: '"MELISSA A. DAUBERT"'
Autor:
Julian E. Garcia, Ian R. Mulrenin, Anh B. Nguyen, Matthew S. Loop, Melissa A. Daubert, Rachel Urrutia, Craig R. Lee
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Hypertensive disorders of pregnancy (HDP) are rising in prevalence and associated with adverse maternal and infant health outcomes. Current guidelines recommend labetalol, nifedipine, and methyldopa as acceptable first-line agents to treat HDP in out
Externí odkaz:
https://doaj.org/article/7590f87bd754486a82906f2f0a359439
Autor:
Melissa A. Daubert, Eric Yow, Huiman X. Barnhart, Ileana L. Piña, Tariq Ahmad, Eric Leifer, Lawton Cooper, Patrice Desvigne‐Nickens, Mona Fiuzat, Kirkwood Adams, Justin Ezekowitz, David J. Whellan, James L. Januzzi, Christopher M. O’Connor, G. Michael Felker
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 10 (2021)
Background NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) is a prognostic biomarker in heart failure (HF) with reduced ejection fraction. However, it is unclear whether there is a sex difference in NT‐proBNP response and whether the
Externí odkaz:
https://doaj.org/article/8202fd89cd6b49ef823af032edb30f12
Autor:
Donna Kam, Henley Wu, Michael Kam, Roman Goldenberg, Joshua Ring, Summer Ferraro, Vinay Malhotra, Melissa A. Daubert, Alexander J. Abramowicz, Aimee Minton, Michael Poon
Publikováno v:
Heart International, Vol 8, Iss 1, Pp e2-e2 (2013)
Coronary computed tomography angiography (CCTA) is increasingly used for the assessment of coronary heart disease (CHD) in symptomatic patients. Software applications have recently been developed to facilitate efficient and accurate analysis of CCTA.
Externí odkaz:
https://doaj.org/article/4aa761909d414c9a86d5e3e48fe51647
Autor:
Dhaval Kolte, Bhaskar Bhardwaj, Michael Lu, Maria C. Alu, Jonathan J. Passeri, Ignacio Inglessis, Gus J. Vlahakes, Santiago Garcia, David J. Cohen, Brian R. Lindman, Susheel Kodali, Vinod H. Thourani, Melissa A. Daubert, Pamela S. Douglas, Wael Jaber, Philippe Pibarot, Marie-Annick Clavel, Igor F. Palacios, Martin B. Leon, Craig R. Smith, Michael J. Mack, Sammy Elmariah
Publikováno v:
JAMA cardiology. 7(9)
In patients with severe aortic stenosis and left ventricular ejection fraction (LVEF) less than 50%, early LVEF improvement after transcatheter aortic valve replacement (TAVR) is associated with improved 1-year mortality; however, its association wit
Autor:
Angela Lowenstern, Nicholas Ng, Hidenobu Takagi, Jennifer A. Rymer, Lynne M. Koweek, Pamela S. Douglas, Jessica M. Duran, Mark Rabbat, Gianluca Pontone, Timothy Fairbairn, Kavitha Chinnaiyan, Daniel S. Berman, Bernard De Bruyne, Jeroen J. Bax, Takashi Akasaka, Tetsuya Amano, Koen Nieman, Campbell Rogers, Hironori Kitabata, Niels P.R. Sand, Tomohiro Kawasaki, Sarah Mullen, Hitoshi Matsuo, Bjarne L. Norgaard, Manesh R. Patel, Jonathan Leipsic, Melissa A. Daubert
Publikováno v:
Lowenstern, A, Ng, N, Takagi, H, Rymer, J A, Koweek, L M, Douglas, P S, Duran, J M, Rabbat, M, Pontone, G, Fairbairn, T, Chinnaiyan, K, Berman, D S, De Bruyne, B, Bax, J J, Akasaka, T, Amano, T, Nieman, K, Rogers, C, Kitabata, H, Sand, N P R, Kawasaki, T, Mullen, S, Matsuo, H, Norgaard, B L, Patel, M R, Leipsic, J & Daubert, M A 2023, ' Influence of Obesity on Coronary Artery Disease and Clinical Outcomes in the ADVANCE Registry ', Circulation. Cardiovascular Imaging (Online), vol. 16, no. 5, e014850 . https://doi.org/10.1161/CIRCIMAGING.122.014850
Background: The relationship between body size and cardiovascular events is complex. This study utilized the ADVANCE (Assessing Diagnostic Value of Noninvasive FFR CT in Coronary Care) Registry to investigate the association between body mass index (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed53a0e85a311bea4a0a8b43441eea82
https://pure.au.dk/portal/da/publications/influence-of-obesity-on-coronary-artery-disease-and-clinical-outcomes-in-the-advance-registry(e4058528-2a0d-4096-9c63-ace223548a1f).html
https://pure.au.dk/portal/da/publications/influence-of-obesity-on-coronary-artery-disease-and-clinical-outcomes-in-the-advance-registry(e4058528-2a0d-4096-9c63-ace223548a1f).html
Autor:
NICHOLAS CAUWENBERGHS, FRANCOIS HADDAD, MELISSA A. DAUBERT, RANEE CHATTERJEE, MICHAEL SALERNO, JESSICA L. MEGA, PAUL HEIDENREICH, ADRIAN HERNANDEZ, MYRIAM AMSALLEM, YUKARI KOBAYASHI, KENNETH W. MAHAFFEY, SVATI H. SHAH, GERALD S. BLOOMFIELD, TATIANA KUZNETSOVA, PAMELA S. DOUGLAS
Publikováno v:
Journal of Cardiac Failure.
Autor:
Mohit, Pahuja, Eric S, Leifer, John-Ross D, Clarke, Tariq, Ahmad, Melissa A, Daubert, Daniel B, Mark, Lawton, Cooper, Patrice, Desvigne-Nickens, Mona, Fiuzat, Kirkwood, Adams, Justin, Ezekowitz, David J, Whellan, James L, Januzzi, Christopher M, O'Connor, G Michael, Felker, Ileana L, Piña
Publikováno v:
Progress in Cardiovascular Diseases. 71:79-85
The GUIDE-IT trial was, a multicenter, randomized, parallel group, unblinded study that randomized patients to having heart failure therapy titrated to achieve an NT-proBNP1000 pg/mL or to usual clinical care.We performed pre-specified subgroup analy
Autor:
Matthew S Loop, Rachel P Urrutia, Jasmine D Johnson, Thomas M Price, Tracy Y Wang, Melissa A Daubert
Publikováno v:
Circulation. 147
Objective: Hypertensive disorders of pregnancy (HDP) are a spectrum of disorders with increasing severity: gestational hypertension, preeclampsia, preeclampsia superimposed on chronic hypertension, and severe preeclampsia/eclampsia. Although factors
Autor:
JOSEPHINE Harrington, ANDREW B. NIXON, MELISSA A. DAUBERT, ERIC YOW, JAMES JANUZZI, MONA FIUZAT, DAVID J. WHELLAN, CHRISTOPHER M. O'CONNOR, JUSTIN EZEKOWITZ, ILEANA L. PIÑA, KIRKWOOD F. ADAMS, G. MICHAEL FELKER, RAVI KARRA
Publikováno v:
Journal of Cardiac Failure.
Autor:
Julian E. Garcia, Melissa A. Daubert, Craig R. Lee, Matthew Shane Loop, Ian R. Mulrenin, Muluneh M. Fashe, Rachel Peragallo Urrutia
Publikováno v:
Expert Opin Drug Metab Toxicol
INTRODUCTION: Hypertensive disorders of pregnancy (HDP) are rising in prevalence, and increase risk of adverse maternal and fetal outcomes. Physiologic changes occur during pregnancy that alter drug pharmacokinetics. However, antihypertensive drugs l